Products billed under this code include FluMist Trivalent (2024/2025), FluMist Trivalent (2025/2026).
Payment limit per 0.2 ML, by effective quarter, 4Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| FluMist Trivalent (2024/2025) | MedImmune | 66019-0311-10 | 10 | $305.81 |
| FluMist Trivalent (2025/2026) | MedImmune, LLC | 66019-0112-10 | 10 | $305.81 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $30.581 | +$0.867 | 0.2 ML | LAIV3 Vaccine Intranasal | v1, posted September 17, 2026 |
| 3Q26 | $29.714 | $0.00 | 0.2 ML | LAIV3 Vaccine Intranasal | v1, posted September 15, 2026 |
| 2Q26 | $29.714 | $0.00 | 0.2 ML | LAIV3 Vaccine Intranasal | v1, posted September 15, 2026 |
| 1Q26 | $29.714 | $0.00 | 0.2 ML | LAIV3 Vaccine Intranasal | v1, posted September 15, 2026 |
| 4Q25 | $29.714 | +$0.843 | 0.2 ML | LAIV3 Vaccine Intranasal | v1, posted September 8, 2026 |
| 3Q25 | $28.871 | $0.00 | 0.2 ML | LAIV3 Vaccine Intranasal | v1, posted March 10, 2026 |
| 2Q25 | $28.871 | $0.00 | 0.2 ML | LAIV3 Vaccine Intranasal | v1, posted March 10, 2026 |
| 1Q25 | $28.871 | $0.00 | 0.2 ML | LAIV3 Vaccine Intranasal | v1, posted December 19, 2025 |
| 4Q24 | $28.871 | – | 0.2 ML | LAIV3 Vaccine Intranasal | v1, posted June 11, 2025 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
